Molecular Medicine : MolMed: AIFA granted authorization to manufacture gene therapies for marketing purposes

COMUNICATO STAMPA. MolMed: AIFA granted authorization to manufacture gene therapies for marketing purposes. Milan, December 1, 2015 – MolMed S.p.A. (MLM.MI) announces that AIFA (Agenzia Italiana del Farmaco) granted the operating facility located in Milan, via Olgettina, 58 (at the San Raffaele Biotechnology Department.

Fonte: : Molecular Medicine : MolMed: AIFA granted authorization to manufacture gene therapies for marketing purposes

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

 

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.